Sepio Capital, LP Forte Biosciences, Inc. Transaction History

Sepio Capital, LP

$1.03 Billion
Q3 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Jul 26, 2021	SELL	$31.5 - $42.5 $300,069 - $404,855	-9,526 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$25.01 - $40.24 $1.23 Million - $1.97 Million	-49,065 Reduced 83.74%	9,526 $326,000
Q4 2020 Feb 10, 2021	BUY	$28.66 - $46.79 $1.15 Million - $1.88 Million	40,191 Added 218.43%	58,591 $2.13 Million
Q3 2020 Nov 12, 2020	BUY	$14.71 - $50.69 $270,664 - $932,696	18,400 New	18,400 $893,000

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$977,456
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $114M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sepio Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sepio Capital, LP with notifications on news.